More recently, Mathewson et al. confirmed by RNA in situ hybridization that CLEC2D mRNA was detected in the two major classes of diffuse gliomas: isocitrate dehydrogenase mutant glioma (IDH-G) and IDH-wild type glioblastoma (GBM) (65). Here, CLEC2D is linked to central nervous system cancer.